Alcon N 2.Linie (ALCE)
SIX
Closed
Oct 9, 2026
Day's Range
57.1252 wk Range
48.16Overview - ALCE - Alcon N 2.Linie
Key Statistics
Valuation
Enterprise Value
26.14B
P/E (Trailing)
‪54.40‬
PEG Ratio
‪-0.54‬
Price / Book
‪1.53‬
EV / EBITDA
‪13.08‬
Profitability
Gross Margin
‪59.33%‬
Profit Margin
‪5.92%‬
Operating Margin
‪14.63%‬
Return on Assets
‪2.79%‬
Return on Equity
‪2.94%‬
Ownership
Shares Outstanding
483.40M
Float
481.83M
Price stats
Beta
‪0.72‬
50-Day Avg
‪57.09‬
200-Day Avg
‪55.28‬
Dividends
Payout Ratio
‪0.00%‬
Peers - ALCE - Alcon N 2.Linie
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on SIX.
- ALCESIXAlcon N 2.Linie+11.63%52-week change54.40P/E (Trailing)‪5.92%‬Profit Margin
- SRT3SIXSartorius AG Preference Shares+8.10%52-week change81.37P/E (Trailing)‪5.47%‬Profit Margin
- STMNSIXStraumann Holding AG+10.53%52-week change42.20P/E (Trailing)‪14.00%‬Profit Margin
- YPSNSIXYpsomed Holding AG+9.86%52-week change22.22P/E (Trailing)‪30.36%‬Profit Margin
- TECNSIXTecan Group AG+39.02%52-week change24.57P/E (Trailing)‪-13.36%‬Profit Margin
- AMSSIXams OSRAM AG+44.33%52-week change-15.21P/E (Trailing)‪-9.73%‬Profit Margin
- SKANSIXSKAN Group AG+23.48%52-week change53.16P/E (Trailing)‪8.25%‬Profit Margin
Profile Summary - ALCE - Alcon N 2.Linie
About
Alcon N 2.Linie is a Swiss pharmaceutical and medical devices company specializing in eye care solutions. The company develops, manufactures, and markets a comprehensive portfolio of products designed to address various ophthalmological conditions and needs. Its offerings include prescription medications for eye…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
